CAN
KNSA icon

Cetera Advisor Networks’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Cetera Advisor Networks’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-43,632
Closed -$608K – 1995
2021
Q2 		$608K Buy
43,632
+1,720
+4% +$26.1K 0.01% 1078
2021
Q1 		$776K Buy
+41,912
New +$857K 0.02% 679

Other funds holding KNSA

PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Cetera Advisor Networks's KNSA Position: Q3 2021 in Review

Cetera Advisor Networks sold out of Kiniksa Pharmaceuticals (KNSA) in Q3 2021, closing a stake of 43,632 shares — an estimated $608K sold.

Cetera Advisor Networks first reported a position in KNSA in Q1 2021 and held it in 2 quarters. The position peaked at $776K in Q1 2021. 101 funds tracked by Wall St. Rank hold KNSA as of Q3 2021.

  • Cetera Advisor Networks reported no remaining Kiniksa Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Cetera Advisor Networks sold 43,632 Kiniksa Pharmaceuticals shares in Q3 2021, an estimated $608K.
  • Cetera Advisor Networks first reported a position in Kiniksa Pharmaceuticals in Q1 2021 and held it in 2 quarters.
  • Cetera Advisor Networks's Kiniksa Pharmaceuticals position peaked at $776K in Q1 2021.
  • 101 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2021.

Based on Cetera Advisor Networks's 13F filing for Q3 2021, filed 16 Nov 2021.